Journal of Pharmaceutical and Biomedical Analysis

Development and validation of a cholate binding capacity method for DMP 504, a bile acid sequestrant
pp. 343-351(9)
Authors: Schreiber M.A.; Moyer K.L.; Mueller B.J.; Ramos M.A.; Green J.S.; White L.; Hedgepeth W.; Juliano K.; Scull J.R.; Hovsepian P.K.

A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma
pp. 353-356(4)
Authors: Shirazi F.H.; Bahrami G.; Stewart D.J.; Tomiak E.; Delorme F.; Noel D.; Goel R.

Omeprazole determination using HPLC with coulometric detection
pp. 357-361(5)
Authors: Sluggett G.W.; Stong J.D.; Adams J.H.; Zhao Z.

Determination of iodide with 1,3-dibromo-5,5-dimethylhydantoin (DBH) in comparison with the ICl-method - Analytical methods of pharmacopeias with DBH in respect to environmental and economical concern. Part 3
pp. 363-377(15)
Authors: Hilp M.; Senjuk S.

Identification of a pharmaceutical packaging off-odor using solid phase microextraction gas chromatography/mass spectrometry
pp. 379-386(8)
Authors: Sides S.L.; Polowy K.B.; Thornquest A.D.; Burinsky D.J.

Voltammetric determination of doxazosin in tablets using rotating platinum electrode
pp. 387-391(5)
Author: Altiokka G.

Flow Injection Determination of levodopa in tablets using a solid-phase reactor containing lead(IV) dioxide immobilized
pp. 393-398(6)
Authors: Marcolino-Junior L.H.; Teixeira M.F.S.; Pereira A.V.; Fatibello-Filho O.

LC determination of atropine sulfate and scopolamine hydrobromide in pharmaceuticals
pp. 399-406(8)
Authors: Ceyhan T.; Kartal M.; Altun M.L.; Tulemis F.; Cevheroglu S.

LC determination of the enantiomeric purity of levamisole using stationary phase with bonded naphthylethylcarbamoylated--cyclodextrin
pp. 407-415(9)
Authors: Dolezalova M.; Tkaczykova M.

A new sensitive and selective spectrophotometric method for the determination of catechol derivatives and its pharmaceutical preparations
pp. 417-424(8)
Authors: Nagaraja P.; Vasantha R.A.; Sunitha K.R.

Different methods for the determination of gestodene, and cyproterone acetate in raw material and dosage forms
pp. 425-436(12)
Authors: Bebawy L.I.; Mostafa A.A.; Refaat H.H.

High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2C19 inhibition evaluation
pp. 437-442(6)
Authors: Bu H.-Z.; Knuth K.; Magis L.; Teitelbaum P.

Adsorptive stripping voltammetric determination of antihypertensive agent: diltiazem
pp. 443-451(9)
Authors: Ghandour M.A.; Aboul Kasim E.; Ali A.M.M.; El-Haty M.T.; Ahmed M.M.

Direct separation of captopril diastereoisomers including their rotational isomers by RP-LC using a teicoplanin column
pp. 453-464(12)
Authors: Owens P.K.; Svensson L.A.; Vessman J.

Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216
pp. 465-475(11)
Authors: Vouillamoz-Lorenz S.; Bauer J.; Lejeune F.; Decosterd L.A.

FIA of vitamin C in blood serum in humans at increasing ethanol concentration
pp. 477-481(5)
Authors: Kleszczewski T.; Kleszczewska E.

Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC
pp. 483-492(10)
Authors: Daraghmeh N.; Al-Omari M.; Badwan A.A.; Jaber A.M.Y.

Analysis of multicomponent formulations containing phenylpropanolamine hydrochloride, caffeine and diazepam by using LC
pp. 493-499(7)
Authors: Ferreyra C.; Ortiz C.

Chiral analysis of drug substance in clinical plasma extracts using achiral HPLC with circular dichroism detection
pp. 501-509(9)
Authors: Williams R.C.; Edwards J.F.; Joshi A.S.; Aubry A.-F.

Determination of astemizole in pharmaceutical preparations using spectrophotometric methods
pp. 511-521(11)
Authors: Gungor S.; Onur F.

Quantitative analysis of metronidazole in intravenous admixture with ciprofloxacin by first derivative spectrophotometry
pp. 523-530(8)
Authors: Vega E.; Sola N.

Rapid and sensitive LC separation of new impurities in trimethoprim
pp. 531-538(8)
Authors: Hess S.; Akermann M.; Ropte D.; Eger K.

Determination of polyvinyl alcohol in a poly(DL-lactide-co-glycolide) matrix by size exclusion chromatography using evaporative light scattering detection
pp. 539-543(5)
Author: Dunn K.D.

Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS
pp. 545-557(13)
Authors: Feng W.; Liu H.; Chen G.; Malchow R.; Bennett F.; Lin E.; Pramanik B.; Chan T.-M.

Characterisation of adhesional properties of lactose carriers using atomic force microscopy
pp. 559-567(9)
Authors: Louey M.D.; Mulvaney P.; Stewart P.J.

LC/MS/MS quantitation of an anti-cancer drug in human plasma using a solid-phase extraction workstation: application to population pharmacokinetics
pp. 569-576(8)
Authors: Penn L.D.; Cohen L.H.; Olson S.C.; Rossi D.T.

Quantitative analysis of dimethyl titanocene by iodometric titration, gas chromatography and NMR
pp. 577-588(12)
Authors: Vailaya A.; Wang T.; Chen Y.; Huffman M.

Photostability and phototoxicity studies on diltiazem
pp. 589-597(9)
Authors: Andrisano V.; Hrelia P.; Gotti R.; Leoni A.; Cavrini V.

LC determination of Z-338, novel gastroprokinetic agent in dog plasma by SCX solid phase extraction
pp. 599-603(5)
Authors: Furuta S.; Miyahara H.; Sugimoto T.; Sano H.

Degradation of dehydroascorbic acid in parenteral nutrition mixtures
pp. 605-611(7)
Authors: Gibbons E.; Allwood M.C.; Neal T.; Hardy G.

Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase
pp. 613-618(6)
Authors: Toft K.G.; Myrset A.H.; Skotland T.

Simultaneous determination of thiamine and pyridoxine in pharmaceuticals by using a single flow-through biparameter sensor
pp. 619-630(12)
Authors: Ortega Barrales P.; Domnguez Vidal A.; Fernandez de Cordova M.L.; Molina Daz A.

A spectrophotometric method for the determination of metoclopramide HCl and dapsone
pp. 631-637(7)
Authors: Revanasiddappa H.D.; Manju B.

Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method
pp. 639-650(12)
Authors: Choo K.-S.; Kim I.-W.; Jung J.-K.; Suh Y.-G.; Chung S.-J.; Lee M.-H.; Shim C.-K.

Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis
pp. 651-661(11)
Authors: Sek L.; Porter C.J.H.; Charman W.N.

Stability indicating HPTLC method for the simultaneous determination of pseudoephedrine and cetirizine in pharmaceutical formulations
pp. 663-667(5)
Authors: Makhija S.N.; Vavia P.R.

Identification of new aqueous chemical degradation products of isophosphoramide mustard
pp. 669-678(10)
Authors: Breil S.; Martino R.; Gilard V.; Malet-Martino M.; Niemeyer U.

Spectrofluorometric determination of ibuprofen in pharmaceutical formulations
pp. 679-683(5)
Authors: Damiani P.C.; Bearzotti M.; Cabezon M.A.

HPTLC determination of nimesulide from pharmaceutical dosage forms
pp. 685-688(4)
Authors: Patravale V.B.; D'Souza S.; Narkar Y.

A validated method for the determination of verapamil and norverapamil in human plasma
pp. 689-695(7)
Author: Sawicki W.s.